Skip to main content
Benjamin Yudkoff, MD, Psychiatry, Newton, MA

Benjamin Louis Yudkoff MD MA


Chief Medical Officer and Co-Founder - Lumin Health (luminhealth.com)

Join to view full profile
  • 10 Langley RdSte 303Newton, MA 02459

  • Phone+1 617-863-8810

  • Fax+1 617-863-8844

Dr. Yudkoff is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Benjamin Yudkoff is co-founder and CMO of Lumin Health - a ketamine and esketamine medical practice with locations in the Boston metro area and the DC area. By way of background: Dr. Yudkoff was the director of the Brigham and Women's Faulkner Hospital Partial Hospital Program and Psychiatric Intervention program. He spearheaded the development of the long acting injectable antipsychotic clinic, the outpatient ECT program, and the ketamine and esketamine program. Specializing in treatment refractory psychiatric illness and program development, he co-founded Lumin Health in 2022 to address treatment refractory depression. Lumin Health is an academically-oriented commercial enterprise. Residents, fellows, and nurse practitioner students train in Lumin Health sites.

    Dr. Yudkoff has received several teaching and professional awards, including honors from Harvard Medical School and the Gold Humanism Society. He continues to supervise Harvard Medical School - Brigham and Women's Hospital residents in psychodynamic psychotherapy.

Education & Training

  • Cambridge Health Alliance
    Cambridge Health AllianceResidency, Psychiatry, 2010 - 2014
  • Rutgers Robert Wood Johnson Medical School
    Rutgers Robert Wood Johnson Medical SchoolClass of 2010
  • Brandeis University
    Brandeis UniversityM.A., Bible and Ancient Near Eastern Studies, 2004 - 2005
  • Brandeis University
    Brandeis UniversityB.A., Biology, Bible and Ancient Near Eastern Studies, Magna Cum Laude, 2000 - 2004

Certifications & Licensure

  • DC State Medical License
    DC State Medical License 2026 - 2028
  • MA State Medical License
    MA State Medical License 2013 - 2028
  • VA State Medical License
    VA State Medical License 2026 - 2028
  • MD State Medical License
    MD State Medical License 2026 - 2027
  • NJ State Medical License
    NJ State Medical License 2026 - 2027
  • NY State Medical License
    NY State Medical License 2026 - 2027
  • Psychiatry
    American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

  • Resident Teaching Award Harvard Medical School, 2011
  • Medical Student Teaching Award Harvard Medical School, 2011
  • Robert Wood Johnson Medical School Psychiatric Achievement Award Robert Wood Johnson Medical School, 2010

Publications & Presentations

PubMed

Abstracts/Posters

  • A New Syllabus for Teaching Schizophrenia to Residents
    Yudkoff B, Harvard Day, 1/1/2014

Lectures

  • A Psychopharmacological Review for the Non-Prescriber: How Medications Impact Therapy 
    Brigham and Women's Faulkner Hospital - 1/1/2017
  • Electroconvulsive Therapy 
    Harvard Medical School - 1/1/2017
  • Treatment of Depression: Innovations from the Field 
    Brigham and Women's Faulkner Hospital - 1/1/2017

Other

  • O brasileiro esta dormindo maL 
    Cohen P, Yudkoff B, Brazilian Magazine
    1/10/2010
  • Psychological Profile of Malaysia's Datuk Seri Anwarlbrahim 
    Post J, Yudkoff B, Privately published article
    1/1/2009
  • Psychological Profile of Sudan's President Omar Hassan al­ Bashir. Financed by the International Criminal Court in its case against President Omar Hassan al­ Bashir 
    Post J, Yudkoff B
    1/1/2009

Authored Content

  • What I Tell Clinicians Who Ask if Their Patient Is "Depressed Enough" For EsketamineJune 2026

Press Mentions

  • Americans Are Using Ketamine to Treat Depression with Lack of Government Regulation
    Americans Are Using Ketamine to Treat Depression with Lack of Government RegulationNovember 22nd, 2022
  • Americans Take Ketamine at Home for Depression with Little Oversight
    Americans Take Ketamine at Home for Depression with Little OversightOctober 30th, 2022

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: